These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28166809)

  • 1. B cells interactions in lipid immune responses: implications in atherosclerotic disease.
    Echeverri Tirado LC; Yassin LM
    Lipids Health Dis; 2017 Feb; 16(1):30. PubMed ID: 28166809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
    Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
    Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scavenger receptors as regulators of natural antibody responses and B cell activation in autoimmunity.
    Jordö ED; Wermeling F; Chen Y; Karlsson MC
    Mol Immunol; 2011 Jun; 48(11):1307-18. PubMed ID: 21333356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation and splicing of scavenger receptor class B type I in human macrophages and atherosclerotic plaques.
    Svensson PA; Englund MC; Snäckestrand MS; Hägg DA; Ohlsson BG; Stemme V; Mattsson-Hulten L; Thelle DS; Fagerberg B; Wiklund O; Carlsson LM; Carlsson B
    BMC Cardiovasc Disord; 2005 Aug; 5():25. PubMed ID: 16122381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis.
    Zhou X; Robertson AK; Rudling M; Parini P; Hansson GK
    Circ Res; 2005 Mar; 96(4):427-34. PubMed ID: 15662027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with malondialdehyde-modified low-density lipoprotein (LDL) reduces atherosclerosis in LDL receptor-deficient mice challenged with Porphyromonas gingivalis.
    Turunen SP; Kummu O; Wang C; Harila K; Mattila R; Sahlman M; Pussinen PJ; Hörkkö S
    Innate Immun; 2015 May; 21(4):370-85. PubMed ID: 25134521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of macrophage scavenger receptors in atherosclerosis.
    Kzhyshkowska J; Neyen C; Gordon S
    Immunobiology; 2012 May; 217(5):492-502. PubMed ID: 22437077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atherosclerosis Susceptibility in Mice Is Independent of the V1 Immunoglobulin Heavy Chain Gene.
    Centa M; Gruber S; Nilsson D; Polyzos KA; Johansson DK; Hansson GK; Ketelhuth DF; Binder CJ; Malin S
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):25-36. PubMed ID: 26564818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An unexpected intriguing effect of Toll-like receptor regulator RP105 (CD180) on atherosclerosis formation with alterations on B-cell activation.
    Karper JC; de Jager SC; Ewing MM; de Vries MR; Bot I; van Santbrink PJ; Redeker A; Mallat Z; Binder CJ; Arens R; Jukema JW; Kuiper J; Quax PH
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2810-7. PubMed ID: 24115036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual role for scavenger receptor class B, type I on bone marrow-derived cells in atherosclerotic lesion development.
    Van Eck M; Bos IS; Hildebrand RB; Van Rij BT; Van Berkel TJ
    Am J Pathol; 2004 Sep; 165(3):785-94. PubMed ID: 15331403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines modulating lipoprotein autoimmunity as a possible future therapy for cardiovascular disease.
    Nilsson J; Fredrikson GN; Björkbacka H; Chyu KY; Shah PK
    J Intern Med; 2009 Sep; 266(3):221-31. PubMed ID: 19702790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scavenger receptors and modified lipoproteins: fatal attractions?
    Zingg JM; Ricciarelli R; Azzi A
    IUBMB Life; 2000 May; 49(5):397-403. PubMed ID: 10902571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scavenger receptors mediate adhesion of activated B lymphocytes.
    Yokota T; Ehlin-Henriksson B; Hansson GK
    Exp Cell Res; 1998 Feb; 239(1):16-22. PubMed ID: 9511720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocytes in atherosclerosis.
    Wigren M; Nilsson J; Kolbus D
    Clin Chim Acta; 2012 Oct; 413(19-20):1562-8. PubMed ID: 22565046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging biomarkers and intervention targets for immune-modulation of atherosclerosis - a review of the experimental evidence.
    Björkbacka H; Fredrikson GN; Nilsson J
    Atherosclerosis; 2013 Mar; 227(1):9-17. PubMed ID: 23177975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization.
    Stoll G; Bendszus M
    Stroke; 2006 Jul; 37(7):1923-32. PubMed ID: 16741184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal immunization programs postnatal immune responses and reduces atherosclerosis in offspring.
    Yamashita T; Freigang S; Eberle C; Pattison J; Gupta S; Napoli C; Palinski W
    Circ Res; 2006 Sep; 99(7):e51-64. PubMed ID: 16946133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scavenger receptors in atherosclerosis: beyond lipid uptake.
    Moore KJ; Freeman MW
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1702-11. PubMed ID: 16728653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals.
    Takahashi K; Takeya M; Sakashita N
    Med Electron Microsc; 2002 Dec; 35(4):179-203. PubMed ID: 12658354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis.
    Rahtu-Korpela L; Määttä J; Dimova EY; Hörkkö S; Gylling H; Walkinshaw G; Hakkola J; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):608-17. PubMed ID: 26848160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.